Lee J. Helman, M.D.
Pediatric Oncology Branch
Head, Molecular Oncology Section
National Cancer Institute
9000 Rockville Pike
Building 31, Room 3A11, MSC 2440
Bethesda, MD 20892
Dr. Helman received his M.D. from the University of Maryland School of Medicine in 1980 magna cum laude, and was elected to Alpha Omega Alpha. He completed his internship and residency in internal medicine at Barnes Hospital Washington University, serving as the chief resident, Washington University VA Medical Service, in 1983. He began his fellowship training at the National Cancer Institute (NCI) in 1983, where he has remained. He became the head of the Molecular Oncology Section of the Pediatric Oncology Branch, NCI, in 1993, and chief of the Pediatric Oncology Branch, NCI, in 1997. He was also named a Deputy Director of the Center for Cancer Research, National Cancer Institute, in 2001. He was named acting scientific director for clinical research, Center for Cancer Research, National Cancer Institute, in 2005, and named as the permanent scientific director in 2007.
Dr. Helman's laboratory currently focuses on three major themes related to the biology and treatment of pediatric sarcomas: (1) the role of insulin-like growth factors on the biology of these tumors; (2) identification of the molecular mechanisms of metastases using animal models of spontaneously metastatic tumors; and (3) translation of these findings into treatments to improve the outcome of patients with pediatric sarcomas.
There are no trials listed for this investigator at this time. Please check back for updates. You may also visit the Search for CCR Trials at NIH to find trials conducted by other investigators.